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Abstract
Background: The homeobox gene Gsx2 (formerly Gsh2) is known to regulate patterning in the
lateral ganglionic eminence (LGE) of the embryonic telencephalon. In its absence, the closely
related gene Gsx1 (previously known as Gsh1) can partially compensate in the patterning and
differentiation of ventral telencephalic structures, such as the striatum. However, the cellular and
molecular mechanisms underlying this compensation remain unclear.
Results: We show here that in the Gsx2 mutants Gsx1 is expressed in only a subset of the ventral
telencephalic progenitors that normally express Gsx2. Based on the similarities in the expression
of Gsx1 and Ascl1 (Mash1) within the Gsx2 mutant LGE, we examined whether Ascl1 plays an
integral part in the Gsx1-based recovery. Ascl1 mutants show only modest alterations in striatal
development; however, in Gsx2;Ascl1 double mutants, striatal development is severely affected,
similar to that seen in the Gsx1;Gsx2 double mutants. This is despite the fact that Gsx1 is expressed,
and even expands, in the Gsx2;Ascl1 mutant LGE, comparable to that seen in the Gsx2 mutant.
Finally, Notch signaling has recently been suggested to be required for normal striatal development.
In spite of the fact that Notch signaling is severely disrupted in Ascl1 mutants, it actually appears to
be improved in the Gsx2;Ascl1 double mutants.
Conclusion: These results, therefore, reveal a non-proneural requirement of Ascl1 that together
with Gsx1 compensates for the loss of Gsx2 in a subset of LGE progenitors.
Background
The homeobox gene Gsx2 (formerly known as Gsh2) has
been shown to be required for correct dorsal-ventral pat-
terning in the embryonic mouse telencephalon [1-3].
Gsx2 accomplishes this by repressing dorsal telencephalic
genes such as Pax6 and promoting the expression of ven-
tral regulators such as Ascl1 (Mash1) and Dlx genes within
ventricular zone (VZ) and subventricular zone (SVZ) pro-
genitors of the lateral ganglionic eminence (LGE).
Although Gsx2 mutants do not survive after birth [4],
analyses at late embryonic stages have demonstrated
severe reductions in markers of striatal projection neurons
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which are derived from the LGE [7-10].
The closely related Gsx1 (Gsh1) is also expressed in the
embryonic ventral telencephalon [11], although no telen-
cephalic phenotype has been reported [5,6]. Despite this,
removal of Gsx1 on the Gsx2 mutant background elimi-
nates nearly all striatal projection neurons and olfactory
bulb interneurons, suggesting that Gsx1 can, at least in
part, compensate for the loss of Gsx2 in the development
of these ventral telencephalic structures. This compensa-
tion, however, is complex because Gsx1 is normally only
present in the medial ganglionic eminence and the ven-
tral-most portion of the LGE. In Gsx2 mutants, Gsx1
expression spreads dorsally to encompass the mutant LGE
at mid-neurogenesis time points (for example, embryonic
day (E)14), which is coincident with the re-establishment
of ventral identity (for example, Ascl1 and Dlx expression)
in the mutant LGE [5,6]. Both Ascl1 and Dlx genes are
known to be required for normal development of the
striatum and olfactory bulb interneurons [12-16]. Moreo-
ver, a recent study [17] suggests that Ascl1 and Dlx genes
control distinct and parallel pathways that act in the spec-
ification of olfactory bulb interneurons. The mechanism
by which Gsx1 compensates for the loss of Gsx2 has not
been fully elucidated. Moreover, the requirement for Ascl1
or Dlx genes in this process is unclear.
In this study we have examined the molecular mecha-
nisms underlying Gsx1-mediated recovery of ventral telen-
cephalic development in Gsx2 mutants. To do this, we
have generated and analyzed Gsx2EGFP mice as well as
Gsx2;Ascl1 double mutants at multiple embryonic stages.
Removal of Ascl1 from the Gsx2 mutant background
results in a telencephalic phenotype nearly identical to the
Gsx1:Gsx2 double mutant [5,6]. These results thus indi-
cate that Ascl1 is an essential component of the Gsx1-
mediated recovery in a subset of LGE progenitors within
the Gsx2 mutant telencephalon.
Results
Gsx1 expression in the Gsx2 mutant telencephalon
Previous studies have shown that Gsx1 expands in the LGE
of the Gsx2 mutant [3,5,6]. Normally, the cells expressing
Gsx1 are confined to the ventral-most portion of the LGE;
however, in Gsx2 mutants the expression of this gene
expands throughout the entire dorsal-ventral extent of the
LGE between E11 and E14. We have generated mice in
which the first exon of Gsx2 is interrupted by an IRES-
enhanced green fluorescent protein (EGFP) cassette so
that EGFP is expressed in place of Gsx2. These mice appear
to faithfully reproduce Gsx2 expression and provide a
short-term fate map of Gsx2 derived cells that no longer
express the protein (Figure 1A–C). Moreover, the
Gsx2EGFP/EGFP embryos lack Gsx2 protein expression, while
still delineating the portion of the LGE that the targeted
Gsx2 gene is being transcribed in by virtue of the EGFP
staining (Figure 1F–H). These mutants exhibit identical
patterning defects to those reported for the previously
available Gsx2 mutant allele [1-4] (data not shown).
Using these mice together with an antibody that detects
both Gsx1 and Gsx2 [18], we were able to examine the
Gsx1 recovery on a cellular level, within the context of the
Gsx2 expression domain.
While the Gsx1/2 antibody staining looks very similar to
that of Gsx2 in the Gsx2EGFP/+ embryos (Figure 1A–E), it
reveals a rather different pattern in the Gsx2EGFP/EGFP
embryos (Figure 1I, J). At E12.5, the cells expressing Gsx1
in the mutant LGE are few in number and largely confined
to its ventral half. This finding is in agreement with previ-
ous Gsx1 gene expression studies [3,5]; however, the cel-
lular resolution afforded by the immunohistochemical
approach revealed that the Gsx1 cells appear mostly at the
border between the VZ and SVZ (Figure 1I, J). This is dif-
ferent from Gsx2 expression in the wild-type LGE where
cells throughout the apical-basal extent of the VZ express
this protein, albeit at different levels of expression (Figure
1B). Previous studies have shown that the expansion of
Gsx1 throughout the Gsx2 mutant LGE is complete
between E14.5 and E16.5 [3,5,6]. This is clearly revealed
by Gsx1/2 staining in the Gsx2EGFP/EGFP mutants at E16.5
(Figure 2G). At this stage, only around half the LGE cells
that would normally express Gsx2 contain Gsx1 staining.
Again, the majority of the Gsx1 expressing cells appear to
line up at the VZ/SVZ boundary (Figure 2H). This is simi-
lar to Gsx1/2 staining in the remnant of the medial gangli-
onic eminence in Gsx2EGFP/+ brains (Figure 2B), and since
this staining does not coincide with the EGFP from the
Gsx2 locus (Figure 2A–C), it is likely to reflect Gsx1
expression in the wild-type medial ganglionic eminence.
Thus, although Gsx1 can at least partially compensate for
Gsx2 [5,6], it does not do so in all cells of the LGE that
would normally express Gsx2 but only in a subpopulation
positioned at the VZ/SVZ boundary.
Relationship between Gsx1 and Ascl1 in the Gsx2 mutant 
LGE
Ascl1 (Mash1) is known to be required for the normal
development of the ventral telencephalon [14-16]. Fur-
thermore, Ascl1 is dependent on Gsx2 for its normal
expression in LGE progenitor cells [1-3], at least at early
stages, before Gsx1 expression expands into the mutant
LGE. Ascl1 is expressed by many cells within the Gsx2EGFP/
+ VZ, although they are mainly located at the VZ/SVZ
boundary (Figure 2D, E). Interestingly, the pattern of
Ascl1 expression in the Gsx2 mutants is very similar to
that of Gsx1 (as revealed by Gsx1/2 staining; Figure 2G–
J), with scattered cells in the VZ and the majority accumu-
lated along the VZ/SVZ boundary. In Gsx1;Gsx2 doublePage 2 of 16
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(for example, E12.5) but at later stages (for example,
E15.5–16.5) it is found at low levels within the presump-
tive LGE region [5,6]. This suggests that although Gsx pro-
teins are not absolutely required for Ascl1 expression in
the LGE, they are positive regulators of its expression. The
overlap in Gsx1 and Ascl1 expression in the Gsx2 mutant
LGE (Figure 2H, J) therefore suggests that Ascl1 may act in
concert with Gsx1 for the compensation observed in Gsx2
mutants.
Expression of Gsx2 in the Ascl1 mutant
Although Ascl1 expression in LGE progenitors has been
shown to require Gsx2 [1-3], the role (if any) of Ascl1 in
regulating Gsx2 expression has not been reported. In
E12.5 Ascl1-/- mutants, we found that Gsx2 (and Gsx1/2)
staining in the LGE was not significantly different from
that observed in wild types (Figure 3A, D and data not
shown). Conversely, at E18.5 we observed a large increase
in the numbers of cells expressing Gsx2 along the dorsal-
ventral aspect of the VZ in the Ascl1 mutants and in certain
cases clusters of Gsx2 expressing cells were found in the
forming striatum (Figure 3E). The expression of Gsx2
coincided with Ki67 staining in many of these clusters
(Figure 3E, F) on closely adjacent sections, suggesting that
despite their ectopic location, these Gsx2 cells may remain
in the cell cycle. Gsx1 expression was not changed in the
LGE of Ascl1 mutants [19] (data not shown). These find-
ings could indicate that, in addition to being downstream
of Gsx genes, Ascl1 may also serve a negative feedback
function to repress Gsx2 in LGE progenitors, particularly
at late embryonic stages.
Gsx2;Ascl1 double mutants exhibit severe striatal defects
To examine the possibility that Ascl1 is required for the
Gsx1-mediated recovery observed in the Gsx2 mutant, we
generated Gsx2;Ascl1 double homozygous mutants and
analyzed the striatum at E18.5. The expression of FoxP1
can be used to mark striatal neurons and, thus, the form-
ing striatum at this stage [20,21]. Staining for this marker
Knock-in of enhanced green fluorescent protein (EGFP) into the Gsx2 locusFigure 1
Knock-in of enhanced green fluorescent protein (EGFP) into the Gsx2 locus. (A, B) EGFP expression in Gsx2EGFP/+ 
embryos (A) recapitulates endogenous Gsx2 expression at E12.5 (B). (C) Note that EGFP expression persists longer than 
Gsx2 protein expression in the lateral ganglionic eminence (LGE; merged image). – (D) The Gsx1/2 antibody detects expres-
sion of Gsx1 and Gsx2 in the ventral telencephalon. (E) Note that the EGFP expression is absent in the septal expression 
domain of the Gsx1/2 antibody (asterisks in D, E, I, J) indicating Gsx1-specific expression. (F-H) Homozygous knock-in of 
EGFP into the Gsx2 locus (Gsx2EGFP/EGFP) (F) results in a loss of function of Gsx2 with no detectable protein expression (G). 
Note that the EGFP expression is more intense in the Gsx2EGFP/EGFP embryos (H) compared to the Gsx2EGFP/+ embryos (A). (I) 
The initial expansion of Gsx1 into the LGE of Gsx2EGFP/EGFPembryos is detectable at E12.5 with an anti-Gsx1/2 antibody. (J) 
Gsx1 expression is not observed in all Gsx2 mutant cells of the LGE (merged image) but found largely at the VZ/SVZ boundary 
(arrows in I, J).
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severely reduced compared to wild types (Figure 4A, B),
which is consistent with previous studies [1-3,5,6]. Unlike
the Gsx2 mutants, however, Ascl1 mutants exhibit more
subtle defects in striatal development [14] and, accord-
ingly, showed a more modest reduction in FoxP1 expres-
sion (Figure 4C). Interestingly, the Gsx2;Ascl1 double
mutants showed an even more severe reduction in FoxP1
staining than the Gsx2 mutants (Figure 4D), indicating
that only a rudimentary striatum is present in these brains.
The striatum is composed of two anatomically and neuro-
chemically distinct compartments termed the patch and
matrix [22]. The striatum-enriched phosphoprotein
DARPP-32 has been shown to mark the forming patch
compartment at perinatal time points [23] (Figure 4E).
DARPP-32 is severely reduced in the Gsx2 mutant striatum
(Figure 4F) [1,2,5,24] while its expression was only mod-
erately reduced in the Ascl1 mutants (Figure 4G). Interest-
ingly, no DARPP-32-positive neurons were observed in
the Gsx2;Ascl1 double mutant striatum (Figure 4H), a
finding that is identical to that previously observed in the
Gsx1;Gsx2 double mutant striatum [5]. Calbindin is
known to mark the matrix compartment in the mature
striatum [22]. As previously reported [5], calbindin
expression is increased in the forming Gsx2 mutant stria-
tum (Figure 4J) while a clear reduction in its expression
was seen in the Ascl1 mutant striatum (Figure 4K). The
rudimentary striatum present in the Gsx2;Ascl1 double
mutant striatum did express calbindin (Figure 4L). Again,
this was similar to that previously observed in the
Gsx1;Gsx2 double mutant striatum [5]. Thus, the similari-
ties in the phenotypes observed in the Gsx2;Ascl1 and
Gsx1;Gsx2 double mutants suggest that Ascl1 is required
for the Gsx1-based striatal recovery in Gsx2 mutants.
In order to determine whether Ascl1 is required down-
stream of Gsx1 in a Gsx2 mutant, we examined the expres-
Expansion of Gsx1 in the Gsx2EGFP/EGFP lateral ganglionic eminence (LGE) occurs in only a subset of cells at the ventricular zone (VZ)/subventricular zon (SVZ) borderFigure 2
Expansion of Gsx1 in the Gsx2EGFP/EGFP lateral ganglionic eminence (LGE) occurs in only a subset of cells at the 
ventricular zone (VZ)/subventricular zone (SVZ) border. (A-C) Control embryos (Gsx2EGFP/+) express Gsx2 and 
enhanced green fluorescent protein (EGFP) throughout the VZ of the LGE at E16.5. In addition, the Gsx1/2 antibody labels 
scattered cells in the SVZ (B) where EGFP expression is observed in the majority of the SVZ (A, C). Asterisks in (A, C) mark 
Gsx1/2 staining in the remnant of the medial ganglionic eminence. Because EGFP expression from the Gsx2 locus is not found 
in this region, it is likely that the staining reflects Gsx1 expression. (G) The expansion of Gsx1 in Gsx2EGFP/EGFP embryos is 
throughout the LGE at E16.5. (F, H) Note that Gsx1 expression in Gsx2EGFP/EGFP embryos is observed only at the VZ/SVZ bor-
der in the LGE (arrows in merged image in (H)) whereas EGFP expression (labeling Gsx2 mutant cells) is observed throughout 
the VZ and the SVZ (F, H). (D, E) Control embryos (Gsx2EGFP/+) express Ascl1 at highest levels near the VZ/SVZ border (D) 
and only in scattered cells of the VZ (merged image with EGFP in (E)). (I) By E16.5, Ascl1 is recovered in the LGE of Gsx2EGFP/
EGFP embryos predominately at the VZ/SVZ border (arrows in (J)), which is similar to the expansion of Gsx1 expression in 
these mutants (G).
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Neural Development 2009, 4:5 http://www.neuraldevelopment.com/content/4/1/5sion of Gsx1 in Gsx2;Ascl1 double mutants. If Ascl1 is
required for Gsx1 to expand throughout the Gsx2 mutant
LGE, then the similarities in the Gsx2;Ascl1 and Gsx1;Gsx2
double mutant phenotypes would be easily explained by
the lack of Gsx1 in LGE progenitors. However, this is not
the case, because we observed both Gsx1 gene expression
and Gsx1/2 staining in the Gsx2;Ascl1 double mutant LGE
(Figure 5C, F). Indeed, the level and extent of this expres-
sion was very similar to that seen in the Gsx2 mutant (Fig-
ure 5B, E). This allows us to conclude that Ascl1 acts
downstream of Gsx1 in the Gsx2 mutant LGE.
Olfactory bulb defects in Gsx2;Ascl1 double mutants
Unlike striatal neurons that are largely produced at
embryonic stages, olfactory bulb interneurons are gener-
ated over a protracted period, starting around E14 and
with the majority produced during the first 2 weeks after
birth [25]. Since Gsx2 mutants die shortly after birth [4],
Increase in progenitor cell markers in the lateral ganglionic eminence (LGE) of Ascl1 mutantsFigure 3
Increase in progenitor cell markers in the lateral ganglionic eminence (LGE) of Ascl1 mutants. (A, D) At E12.5, 
Ascl1 mutants express Gsx2 in a relatively normal pattern in the LGE compared to wild type. Note the odd morphology in the 
developing medial ganglionic eminence (MGE) of Ascl1 mutants (asterisk in (D)). (B, E) By E18.5, Gsx2 protein expression is 
increased in the entire LGE region of Ascl1 mutants (E) compared to controls (B). These ectopic Gsx2 positive cells are 
observed in the SVZ and striatum, many appearing as clumps of cells stuck in the parenchyma (arrow in (E)). (C, F) Dividing 
cells labeled by Ki67 expression are also increased in the Ascl1 mutant LGE area (F) compared to control (C). Similar to Gsx2, 
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Neural Development 2009, 4:5 http://www.neuraldevelopment.com/content/4/1/5only the olfactory bulb interneurons that are generated at
embryonic stages can be assayed. Previous studies
[1,3,5,6] have shown that Gsx2 mutants exhibit defects in
the development of these neurons at birth. The olfactory
bulb interneurons produced at embryonic time points
have been suggested to originate, at least in part, from the
dorsal (d)LGE [26]. We have recently shown that the zinc
finger transcription factor Sp8 marks the dLGE as well as
olfactory bulb interneurons [27] (Figure 6A, E). In Gsx2
mutants, the number of Sp8 expressing cells is dramati-
cally reduced in both the dLGE and olfactory bulb (Figure
6B, F) [27]. Although Ascl1 mutants have been shown to
have olfactory bulb interneuron defects [14,28], the
expression of Sp8 in these mutants is not reduced in the
dLGE at E15.5 [17]; rather, it appears as if more cells are
seen in this region streaming laterally towards the ventro-
lateral telencephalon by E18.5 (Figure 6C). Moreover,
there appear to be similar numbers of Sp8-positive cells
within the Ascl1 mutant olfactory bulb compared to wild
type, although their distribution appears somewhat disor-
ganized (Figure 6G). Conversely, in the Gsx2;Ascl1 double
mutants the expression of Sp8 is reduced, even when com-
pared to the Gsx2 mutants (Figure 6B, D). Indeed, most
sections of the double mutant olfactory bulb lack any Sp8-
positive cells (Figure 6H).
Sp8 is required for normal development of the calretinin
(CR)-expressing subtype of olfactory bulb interneurons
[27]. In addition to the dLGE, the septum has also been
suggested to give rise to olfactory bulb interneurons [29],
and more recent results suggest that the septum may also
represent a region where the CR interneurons originate
[30,31]. Indeed, CR positive neurons can be seen in the
wild-type dLGE and even more so in the septum at E18.5
(Figure 7A) as well as in the forming glomerular layer of
the olfactory bulb (Figure 7E). As might be predicted from
the Sp8 staining, the Gsx2 mutants showed reductions in
CR interneurons (Figure 7B, F), while the Ascl1 mutants
did not appear to exhibit reduced numbers of CR positive
cells (Figure 7G) and at least in portions of the dLGE may
even contain increased numbers of these cells (Figure 7C).
Furthermore, the Gsx2;Ascl1 double mutants showed a
more severe reduction in CR staining than the Gsx2
mutants (Figure 7D, H). Previous studies [1,3,5,6,14,28]
have shown that Gsx2 (Figure 7J) and Ascl1 mutants (Fig-
ure 7K) exhibit reductions in glutamic acid decarboxylase
(67 kDa) (GAD67)-positive olfactory bulb interneurons
(GAD67 is a rate limiting enzyme in GABA production).
These appear to be compounded in the Gsx2;Ascl1 double
mutants where essentially no GAD67-positive cells were
observed in the olfactory bulb at this time point (Figure
7L). Taken together, these data suggest that Ascl1 func-
tions downstream of Gsx2 to regulate aspects of olfactory
bulb interneuron diversity. Indeed, it appears that Gsx2 is
required for many, if not all, of the interneuron subtypes
to be properly generated, while Ascl1 is more crucial for
the generation of GAD67 (that is, GABAergic) and
dopaminergic interneurons [28].
Notch signaling in Gsx2;Ascl1 double mutants
Previous studies have shown that Notch signaling is
required for normal LGE/striatal development [16,32].
Moreover, Ascl1 mutants exhibit reduced Notch signaling
[14,16]. It is possible, therefore, that the phenotypes
observed in the Gsx2;Ascl1 double mutants are a result of
compound effects of a loss of Notch signaling together
with distinct Gsx2 requirements. To address this, we
examined the expression of factors in the Notch signaling
pathway, Ngn2, Dll1 and Hes5, in relation to Gsx1/2
expression. In Gsx2 mutants, Ngn2 was shifted ventrally
into the LGE as previously described (Figure 8F) [1-3],
although it appeared to be directly abutting the ventrally
shifted Gsx1/2 staining (Figure 8B). Indeed, both Dll1
(Figure 8J) and Hes5 (Figure 8N) were continuously
expressed throughout the Gsx2 mutant LGE. In the Ascl1
mutants, Gsx1/2 staining was present up to the normal
pallio-subpallial boundary (Figures 3A and 8C) and Ngn2
staining abutted it at its normal ventral position (compare
Figure 8E and 8G). This theoretically leaves no proneural
gene expression in the LGE and, in fact, both Dll1 (Figure
Removal of Ascl1 on the Gsx2 mutant background exacerbates the Gsx2 mutant phenotype in the striatumFigure 4 (see previous page)
Removal of Ascl1 on the Gsx2 mutant background exacerbates the Gsx2 mutant phenotype in the striatum. (A) 
FoxP1 expression labels striatal projection neurons at E18.5. (B) In Gsx2 mutants, the expression domain of FoxP1 in the stria-
tum is severely reduced. (D) Removal of Ascl1 on the Gsx2 mutant background (Gsx2;Ascl1 double mutant) results in a more 
severe effect on the FoxP1 expression domain compared to Gsx2 mutants (compare (D) to (B)). (C) Ascl1 mutants display rel-
atively normal expression of FoxP1 in the striatum. (E-G) Gsx2 mutants also exhibit a severe reduction in DARPP-32 expres-
sion (F), which is enriched in early born striatal neurons at E18.5 in controls (E) and Ascl1 mutants (G). (H) Gsx2;Ascl1 double 
mutants display a more severe phenotype in DARPP-32 expression compared to Gsx2 mutants (compare (H) to (F)). Note that 
Gsx2;Ascl1 double mutants display a complete loss of DARPP-32 positive neurons in the striatum (H). The only DARPP-32 
staining observed in the double mutant striatum is in fibers (arrow in (H)), which presumably arise from the cortical DARPP-32 
expressing neurons. (I, J, L) Calbindin (CB) expression labels the later born striatal neurons at E18.5 (I) and is upregulated in 
the SVZ of Gsx2 mutants (J) and Gsx2;Ascl1 double mutants (L). (K) Ascl1 mutants exhibit a noticeable reduction in CB expres-
sion in the striatum. ac, anterior commissure.Page 7 of 16
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ously described [14]. This is not the case in Gsx2;Ascl1
double mutants, where Ngn2 was observed to extend ven-
trally into the double mutant LGE and improvement in
Dll1 (Figure 8L) and Hes5 (Figure 8P) expression was
observed, at least within the presumptive LGE region,
compared to Ascl1 mutants. This indicates that the Notch
signaling defects observed in Ascl1 mutants are, in part,
due to Gsx2 expression remaining in the LGE. Thus, it
appears that Ascl1 performs a non-proneural function in
Gsx1 expands throughout the Gsx2;Ascl1 mutant lateral ganglionic eminence (LGE)Figur  5
Gsx1 expands throughout the Gsx2;Ascl1 mutant lateral ganglionic eminence (LGE). (A-C) Gsx1 expression is 
barely present in the E16.5 wild type LGE (A) but appears to be expressed similarly in Gsx2 (B) and Gsx2;Ascl1 mutant (C) 
LGEs. (D-F) The Gsx1/2 antibody can be used in Gsx2 mutants to visualize Gsx1 protein expression and not only is gene 
expression expanded in the mutants compared to wild type (D) but Gsx1 protein is found in a similar pattern in the Gsx2 
mutant (E) and Gsx2;Ascl1 mutant (F) LGEs. The Gsx1/2 staining in the wild type mostly reflects Gsx2 expression since very lit-
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Neural Development 2009, 4:5 http://www.neuraldevelopment.com/content/4/1/5the Gsx1-mediated recovery observed in the Gsx2 mutant.
Interestingly, it also seems that Ascl1 plays a role in the
timing of the Gsx1 expansion into the Gsx2 mutant LGE
as the Gsx2;Ascl1 double mutants showed much less Gsx1
(as marked by Gsx1/2 staining) expression in the pre-
sumptive LGE at E12.5 (Figure 8D) when compared to
later time points (for example, E16.5; Figure 5C, F).
Discussion
The study of knock-out mice is essentially an investigation
into the compensatory mechanisms (or lack thereof)
when any given gene is inactivated. In the case of Gsx2, it
has previously been shown that Gsx1 is involved in the
partial recovery observed in these mutants [5,6]. What
remained unclear was why the Gsx1-dependent compen-
sation was not more effective in restoring normal develop-
ment. In addition to a delayed upregulation of Gsx1 in the
Gsx2 mutant LGE [5,6], we provide novel data here show-
ing that Gsx1 is expressed only in a subset of LGE cells that
would normally express Gsx2. Interestingly, these cells are
largely located at the boundary between the VZ and SVZ,
similar in location to that of Ascl1 expressing cells. Based
on the facts that the striatal phenotype of the Gsx2;Ascl1
mutants is nearly identical to that observed in Gsx1;Gsx2
mutants [5,6] and that Gsx1 expands in the Gsx2;Ascl1
mutants in a similar way to that observed in Gsx2
mutants, we conclude that Ascl1 is required downstream
of Gsx1 for this recovery. These findings suggest that there
Gsx2;Ascl1 double mutants exhibit a more severe phenotype in the formation of the dorsal lateral ganglionic eminence (dLGE) and the generation of olfactory bulb interneuronsFigur 6
Gsx2;Ascl1 double mutants exhibit a more severe phenotype in the formation of the dorsal lateral ganglionic 
eminence (dLGE) and the generation of olfactory bulb interneurons. (A, B) The Sp8 expression domain in the dLGE 
is reduced in Gsx2 mutants (B) compared to controls (A). (D) Gsx2;Ascl1 double mutants exhibit a more severe reduction in 
the expression of Sp8 in the dLGE (D) compared to Gsx2 mutants (B). (C) Ascl1 mutants maintain Sp8 expression in the dLGE 
and may have a slightly expanded expression domain. (E, F) Sp8 expressing interneurons are reduced in Gsx2 mutant olfactory 
bulb (F) compared to controls (E). (H) Gsx2;Ascl1 mutant displays nearly a complete loss of Sp8 expression in the olfactory 
bulb. (G) Sp8 expression is observed in Ascl1 mutant olfactory bulbs, but in a slightly disorganized pattern (compare (G) to 
(E)). gl, glomerular layer.
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Olfactory bulb interneuron subtype specification in Gsx2, Ascl1 and Gsx2;Ascl1 mutantsFigure 7
Olfactory bulb interneuron subtype specification in Gsx2, Ascl1 and Gsx2;Ascl1 mutants. (A-H) Calretinin (CR) 
staining in the dLGE (A-D) and olfactory bulb (E-H) in E18.5 wildtype (A, E), Gsx2 mutant (B, F), Ascl1 mutant (C, G) and 
Gsx2;Ascl1 mutants (D, H). Note that CR cells in the dLGE and olfactory bulb are severely depleted in Gsx2 and Gsx2;Ascl1 
mutants while there appear to be similar if not more numbers of CR neurons in the Ascl1 mutants compared to wild type. (J, 
L) GAD67 (glutamic acid decarboxylase (67 kDa)) staining is severely reduced in Gsx2 mutants (J) and nearly absent in 
Gsx2;Ascl1 mutants (L). (I, K) In comparison, Ascl1 mutants (K) show a more modest reduction in GAD67 staining but it is still 
quite severe when compared to the wild-type olfactory bulb (I). GCL, granule cell layer; GL, glomerular layer.
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Neural Development 2009, 4:5 http://www.neuraldevelopment.com/content/4/1/5are Ascl1-dependent and Ascl1-independent pathways for
LGE development. This is in agreement with recent stud-
ies by Long et al. [17,19] showing that Dlx1/2 and Ascl1
regulate parallel and overlapping pathways in LGE speci-
fication. Furthermore, our results indicate that the Ascl1-
dependent pathway for LGE specification appears to be
independent of its well-known role in regulating the
Notch signaling pathway.
The mechanism by which Gsx1 is upregulated in the Gsx2
mutant LGE has been unclear. It does not appear that
Gsx2 represses Gsx1 expression because only a subset of
the cells that normally express Gsx2, particularly those at
the VZ/SVZ boundary, are Gsx1-positive in the Gsx2
mutant LGE. It seems possible, therefore, that Gsx1 can
only be expressed in certain cell types or in cells that have
reached a particular level of maturation (that is, cells tran-
sitioning from the VZ to the SVZ). Indeed, it appears that
Gsx1-positive cells in the medial ganglionic eminence
region also reside largely in the VZ/SVZ boundary region
(for example, Figure 2C). Interestingly, at early stages
(that is, E12.5) in the Gsx2 mutants, the LGE SVZ does not
form, and only after Gsx1 has expanded throughout the
mutant LGE (that is, by E14–15) does the it do so in this
mutant [2,3,5]. Together with the current findings, these
results suggest that Gsx1 may be expressed in more mature
progenitors and might even play a role in the maturation
process.
Ascl1 has previously been implicated in the development
of the striatum and olfactory bulb interneurons [14-
17,28]. In general, however, the requirement for Ascl1 in
striatal and olfactory bulb development is not as great as
that for Gsx2. In fact, the striatum of the Ascl1 mutant is
only slightly reduced in size when compared to the wild
type [14] (Figure 4). Moreover, the reduction in dopamin-
ergic and GABAergic olfactory bulb interneurons [28] is
not as severe as that observed in Gsx2 mutants [5,6].
Although striatal development is only modestly affected
by the loss of Ascl1, we show here that the added loss of
Gsx2 results in a nearly complete loss of striatal develop-
ment. This result is identical to that previously reported
for Gsx1;Gsx2 double mutants [5,6]. Thus, Ascl1 is abso-
lutely essential for the Gsx1-mediated recovery observed
in Gsx2 mutants. While Ascl1 appears to be downstream
of Gsx2 [1-3], the relationship between Gsx1 and Ascl1
appears to be more complex. The loss of Gsx1 and Gsx2
severely depletes the expression of Ascl1 throughout
embryogenesis [5,6], suggesting that both are genetically
upstream; however, our findings here also demonstrate a
delay in the expression of Gsx1 in Gsx2;Ascl1 double
mutants at early stages (for example, Figure 8D), poten-
tially implicating Ascl1 in feedback regulation of Gsx1
expression.
Ascl1 is a known regulator of the Notch signaling pathway
[14,16] and Notch signaling has previously been impli-
cated in controlling striatal development [16,32]. It does
not seem that the striatal defects observed in the
Gsx2;Ascl1 double mutants, described here, are simply
due to compound effects of the loss of Gsx2 and impaired
Notch signaling because we observed an improvement in
Notch signaling (as indicated by Hes5 and Dll1 expres-
sion) within LGE progenitors of the Gsx2;Ascl1 double
mutants compared to Ascl1 mutants. Our interpretation of
this result is that Gsx2;Ascl1 mutants are similar to Gsx2
mutants in that Ngn2 is allowed to expand ventrally into
the LGE and, as a result, Notch signaling is improved.
Clearly, Ascl1 plays a role in regulating Notch signaling
within LGE progenitors [14,16]; however, the fact that
striatal development is not more severely affected in the
Ascl1 mutant could suggest that Gsx2 normally works
through another gene encoding a basic helix-loop-helix
(bHLH) factor to regulate aspects of LGE neurogenesis.
Notch signaling in the lateral ganglionic eminence (LGE) of Gsx2;Ascl1 mutants is improved from that in Ascl1 mutantsFigure 8 (see previous page)
Notch signaling in the lateral ganglionic eminence (LGE) of Gsx2;Ascl1 mutants is improved from that in Ascl1 
mutants. (A)_Gsx1/2 staining in the E12.5 wild type ventral telencephalon. (B, C) Gsx1/2 staining illustrates the expansion of 
Gsx1 in the Gsx2 mutant LGE (B) as well as the expression of Gsx proteins in the Ascl1 mutant LGE (C); arrows point to the 
dorsal limit of Gsx expression. (D) Note that the Gsx1 expansion is delayed in Gsx2;Ascl1 mutants at this stage but, as shown 
earlier, this recovers at later stages. (E, F, H) The proneural protein Ngn2 is normally expressed in pallial progenitors (E) but 
in the Gsx2 (F) and Gsx2;Ascl1 mutants (H) the ventral limit of Ngn2 expression (arrows in (F, H)) has expanded ventrally into 
the mutant LGE. (G) In contrast, the ventral limit of Ngn2 expression in Ascl1 mutants (arrow) appears to be similar to that in 
wild type (E). (I-P) The status of Notch signaling can be assessed by the expression of Dll1 and Hes5. In wild types, Dll1 (I) and 
Hes5 (M) are expressed in ventricular zone (VZ) progenitors along the dorsal-ventral axis of the telencephalon. As is the case 
in the wild types, Gsx2 mutants appear to express Dll1 (J) and Hes5 (N) throughout the telencephalic VZ, while the Ascl1 
mutants exhibit expression only in the dorsal telencephalon (K, O) corresponding with Ngn2 expression. Although the 
Gsx2;Ascl1 mutants do not show Dll1 (L) and Hes5 (P) expression in the ventral-most telencephalon (that is, medial ganglionic 
eminence (MGE) remnant indicated by asterisk) these Notch effectors are expressed in the mutant LGE progenitors unlike the 
case in Ascl1 mutants. Asterisks in (C, D, G, H, K, L, O, P) indicate the remnant of the MGE.Page 12 of 16
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Ascl1 mutants was that Gsx2 expression appeared to be
increased at perinatal stages. This is not the case at early
time points (for example, E12.5) and suggests that Ascl1
may play a role in depleting the Gsx2 progenitors during
embryogenesis. The increased Gsx2 in the Ascl1 mutant
LGE correlated well with the expression of Sp8, a zinc fin-
ger transcription factor that has previously been shown to
be dependent on Gsx2 expression [27].
Previous studies have described a reduction in dopamin-
ergic and GABAergic interneurons in the Ascl1 mutants
[14,28]; however, no data on other subtypes have been
provided. We show here that unlike the dopaminergic and
GABAergic subtypes, the CR interneurons are not reduced
and may, in fact, be increased. The neurotransmitter of
this subtype remains somewhat unclear. Recent reports
suggests that as few as 14% are GABAergic [33], while oth-
ers suggest that most if not all are GABAergic [30,34]. Our
data seem to support the former possibility (at least at this
stage of development) since the reduction in GABAergic
neurons (as marked by GAD67) is not paralleled by CR-
positive cells in the Ascl1 mutant olfactory bulb. We have
recently shown that the zinc finger transcription factor
Sp8 is required for the normal development of the CR
interneurons in the olfactory bulb [27]. Accordingly, we
found that in Ascl1 mutants at late stages of development,
Sp8 staining is maintained in the dLGE and olfactory
bulbs. Because Gsx2 is required for Sp8 expression in the
dLGE and the latter is essential for normal CR interneuron
production, it seems likely that the sequential expression
of these two transcription factors cooperate to generate
this interneuron subtype. However, despite that Gsx2
appears to function upstream of Ascl1, this bHLH factor
does not actively promote CR interneuron development.
The origin of distinct subtypes of olfactory bulb interneu-
rons has recently been the subject of considerable atten-
tion. Kohwi et al. [30] have recently suggested that CR
interneurons arise from pallial and septal regions but not
the dLGE. On the other hand, De Marchis et al. [35] found
that these interneurons were generated from the postnatal
region of the SVZ that directly derives from the dLGE. In
support of this, Merkle et al. [31] showed that at least
some CR neurons are derived from the rostral dorsal SVZ
(a likely derivative of the dLGE). Although CR interneu-
rons start to be produced at embryonic time points, a
recent study by Batista-Brito et al. [36] have shown that
most are generated at postnatal time points. Our data
show that at least a few CR neurons are present in the late
embryonic dLGE and that Ascl1 mutants appear to exhibit
enhanced CR neuron production in the dLGE and possi-
bly olfactory bulb. Thus, Ascl1 may play a role in the tem-
poral regulation of CR interneuron production from the
dLGE and its SVZ derivatives. In any case, our findings
clearly demonstrate that the dLGE is a significant source of
CR interneurons that are generated at embryonic time
points; however, we cannot exclude the contribution of
the septum in the generation of these interneurons as
shown by Merkle et al. [31], particularly at early postnatal
stages. Indeed, Gsx2 is expressed at high levels in both the
dLGE as well as in the dorsal portion of the septum (Fig-
ure 2) and CR staining in the septal region is also lost in
the Gsx2 mutant (Figure 7). Regardless of their origin, it
seems that all subtypes of olfactory bulb interneurons, at
least at embryonic time points, require Gsx2 for their nor-
mal production.
Conclusion
Our data show that Gsx1 compensates for the loss of Gsx2
gene function in only a subpopulation of the LGE progen-
itors that normally express Gsx2, which may explain why
the compensation is not more complete. Additionally, we
show that Ascl1 is an obligate factor for Gsx1 in the recov-
ery process and that this is independent of its well-known
proneural function.
Methods
Gsx2 [4] and Ascl1 [37] mice were genotyped as previously
described [2,14]. Interbreeding between Gsx2 and Ascl1
heterozygotes was performed to generate Ascl1;Gsx2 dou-
ble heterozygotes, which were subsequently crossed to
generate Ascl1;Gsx2 double homozygous mutants.
Gsx2EGFP knock-in mice were generated by inserting an
IRES-EGFP-pA cassette (Clonetech, Mountain View, CA,
USA) into the first exon of Gsx2 between the NotI and NcoI
sites (Figure 9A). Specifically, a 9-kb genomic fragment
encompassing the Gsx2 locus was isolated by a HindIII
digest of a Gsx2-positive 129 BAC and subcloned into the
HindIII site of pBluescript SK (Stratagene, La Jolla, CA,
USA). The targeting vector backbone was previously
described in Bell et al. [38]. A 6.4-kb Nco1/Spe1 fragment
from the 9-kb Gsx2 genomic region was blunted and sub-
cloned into the Hpa1 site of cre/lox targeting vector to be
used as the 3' homology arm. A 1-kb HindIII/Not1 frag-
ment from the 9-kb Gsx2 genomic region was blunted and
subcloned into the Sma1 site of pBluescript SK (called
5'arm-PBS). The pIRES2-EGFP vector (Clonetech) was
digested with AflII, blunted, and redigested with Nhe1 to
release IRES-EGFP. IRES-EGFP was cloned into 5'arm-
PBS, which was digested with Sal1, blunted, and redi-
gested with Spe1 (5'arm-EGFP-PBS). The 5'arm-IRES-
EGFP was released with a Xho1 digest that was blunted
and subcloned into the Pme1 site of the cre/lox targeting
vector. The Gsx2EGFP vector was linearized with Sal1 and
electroporated in W4 embryonic stem (ES) cells (reviewed
in [39]) and selected with G418 and gancyclovir. Cor-
rectly targeted cells were identified by PCR (Figure 9A, B)
using the following primer pairs to generate products spe-Page 13 of 16
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Targeting scheme to generate the Gsx2EGFP knock-in alleleFigure 9
Targeting scheme to generate the Gsx2EGFP knock-in allele. (A) Using homologous recombination in embryonic stem 
cells an IRES-enhanced green fluorescent protein (EGFP) cassette was inserted in the first exon of the Gsx2 between an Nco1 
and Not1 site. This removed 125 bp of the coding region of the first exon but left the exon-intron structure intact. The polyA 
signal at the end of the IRES-EGFP cassette effectively terminated the message and, as shown in Figure 1, no Gsx2 protein is 
observed when the Gsx2EGFP allele is bred to homozygosity. The Neomycin (Neo) cassette was removed by breeding the mice 
with -actin-Flpase mice [38]. These Gsx2EGFP minus Neo mice were exclusively used in this study. (B) Correctly targeted 
embryonic stem cells were identified using the primers indicated as half arrows in (A). (C) Embryos are genotyped using prim-
ers to detect the Gsx2EGFP allele and using Gsx2 primers that include one sequence in the deleted region of the first exon. M, 






















































Neural Development 2009, 4:5 http://www.neuraldevelopment.com/content/4/1/5cific for the correctly targeted Gsx2EGFP/+ allele: internal
primer 1 (5'-cctccgcttctgttgtgact-3') with internal primer 2
(5'-cctaggaatgctcgtcaagaag-3'), which gave an 837 bp
product, and an external primer (5'-
cctccactacaaggccacatac3') with internal primer 2, which
generated a 1,170 bp product, specific for the correctly tar-
geted Gsx2EGFP/+ allele. Two different targeted ES cell lines
were used for blastocyst injection by the Cincinnati Chil-
dren's Hospital Medical Center transgenic facility. Germ-
line transmission was tested by crossing the chimeras with
C57/B6 mice to obtain agouti offspring. F1 Gsx2EGFP/+
mice were bred to -actin-FLPe (enhanced Flpase) mice
[40] obtained from Jackson Laboratory, Bar Harbor, ME,
which resulted in the Neomyocin cassette flanked by FLP
recombinase target (FRT) sites to be removed (Figure 9A).
Embryos derived from Gsx2EGFP/+crosses were genotyped
with the following primers: internal 2 (5'-cctaggaatgctcgt-
caagaag-3') with Gsx2 int5A (5'-catcaccatcaccagcccc-3'),
which generated a 225 bp product specific for the knock-
in allele; and Gsx2-Int5B (5'-ccacggagattccactgcc 3') with
Gsx2-1437 (5'-gcatccaccccaaatctcagtc-3'), which generated
a 298 bp product specific for the Gsx2 wild-type allele
(Figure 9C). The Gsx2-Int5b primer binds in the deleted
region of exon 1 before the Nco1 site so homozygous
mutants Gsx2EGFP/EGFP do not have a wild-type band.
For staging of embryos, the morning of vaginal plug detec-
tion was designated as E0.5. At least three embryos of each
genotype were examined for every stage studied and
marker used. Embryos were fixed overnight in 4% parafor-
maldehyde at 4°C, rinsed extensively in phosphate-buff-
ered saline and cryoprotected in 30% sucrose before
sectioning at 12–14 m on a cryostat. Sections were thaw-
mounted onto SuperFrost®/Plus slides (Fisher Scientific,
Pittsburgh, PA, USA) and stored at -20°C until used.
For immunohistochemistry, primary antibodies were
used at the following concentrations: rabbit anti-Ascl1
(Mash1; 1:1,000; provided by J Johnson); rabbit anti-cal-
bindin (1:2,500; provided by P Emson); goat anti-cal-
retinin (1:2,000; Millipore, Billerica, MA, USA); rabbit
anti-Dll (pan DLX; 1:400; provided by J Khotz); rabbit
anti-FoxP1 (1:4,000; provided by E Morissey); rabbit anit-
GAD67 (1:1,000; Millipore); goat anti-GFP (1:5,000;
Abcam, Cambridge, MA, USA); rabbit anti-Gsx2 (1:5,000;
[2]); rabbit anti-Gsx1/2 (1:2,000; provided by M Gould-
ing); rabbit anti-Ki67 (1:1,000; Novocastra, Newcastle,
UK); rabbit anti-Ngn2 (1:1,000; provided by M
Nakafuku); rabbit anti-Sp8 (1:500; [26]). The secondary
antibodies for brightfield staining were biotinylated swine
anti-rabbit antibodies (1:200; DAKO, Glostrup, Den-
mark) and biotinylated horse anti-goat antibodies (1:200;
Vector Laboratories, Burlingame, CA, USA). For visualiza-
tion, the ABC kit (Vector Laboratories) followed by diami-
nobenzidine (DAB; Sigma, St. Louis, MO, USA) as the
final chromogen were utilized. The secondary antibodies
for fluorescent staining were donkey anti-goat antibodies
conjugated to Cy2 (Jackson Immunoresearch, West
Grove, PA, USA), and donkey anti-rabbit antibodies con-
jugated to Cy3 (Jackson Immunoresearch).
In situ hybrization histochemistry was performed using
digoxygenin-labeled cRNA probes as described in Tores-
son et al. [41]. Probes used were Gsx1 [5], Hes5 and Dll1
[14].
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